Preclinical development of novel PD-L1 tracers and first-in-human study of [68Ga]Ga-NOTA-RW102 in patients with lung cancers is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 1.0. It has been cited 34 times, with 25 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0.481
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 25 citers.
National Institutes of Health
Grant: P30 CA014520 and T32 CA009206
National Key Research and Development Program of China
Grant: 2020YFA0909000
University of Wisconsin – Madison
Grant: N.A.
National Natural Science Foundation of China
Grant: 82372014 and 82171972
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5T32CA009206-18
U.W. RADIOLOGICAL SCIENCES TRAINING PROGRAM
NCI NIH HHS
Grant: P30 CA014520
NCI NIH HHS
Grant: T32 CA009206
FWCI
6.13
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals